Trevor Lowenthal

With emphasis on biotechnology, Trevor focuses his portfolio on undervalued micro and small-cap companies. As a contributor to TalkMarkets, he hopes to elucidate undervalued companies that are exploring revolutionary treatment modalities for a wide spectrum of rare and devastating medical conditions...